Table 1 Demographic, medical background and infectious agents involved in IE hospitalizations
2010–2018 | |
|---|---|
Number of patients, n | 7574 |
Male, n (%) | 4308 (56.9) |
Age, years (SD) | 68.3 ± 17.3 |
Age groups, n (%) | |
< 18 | 91 (1.2) |
18–39 | 503 (6.6) |
40–59 | 1253 (16.5) |
60–79 | 3565 (47.1) |
≥ 80 | 2162 (28.5) |
Length of hospital stay, days (SD) | 29.3 ± 28.7 Median 21 |
Medical background, n (%) | |
Diabetes mellitus | 2016 (26.6) |
Arterial hypertension | 2828 (37.3) |
Atrial fibrillation | 1876 (24.8) |
HIV | 133 (1.8) |
CRF | 887 (11.7) |
CRF on Hemodialysis | 324 (4.3) |
Non-rheumatic cardiac valve disease | 1590 (21.0) |
Rheumatic valve disease | 709 (9.4) |
Cardiac valve prosthesis | 914 (12.1) |
Cardiac implantable electronic devices | 649 (8.6) |
Coronary artery disease | 970 (12.8) |
Previous PCI | 108 (1.4) |
Previous CABG | 183 (2.4) |
Congenital heart disease | 42 (1.0) |
Cancer | 1018 (13.4) |
COPD | 702 (9.3) |
Opioid consumption | 103 (1.4) |
Chronic hepatic disease | 366 (4.8) |
Infectious agents, n (%) | |
Staphylococcus | 1242 (16.4) |
Streptococcus | 1030 (13.6) |
Enterococcus | 535 (7.1) |
Gram-negative | 898 (11.9) |
Anaerobes | 20 (0.3) |
Fungi | 10 (0.1) |
Brucella | 9 (0.1) |